Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | PNP | P00491 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.64 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.64 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.60 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.60 |
| ▸ | POLA1 | P09884 | 1/20 | 0.59 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.55 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.55 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | PIM1 | P11309 | 1/20 | 0.52 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.52 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Deoxyguanosine SCHEMBL1981362 | 1.00 | POLB (0.67) | POLBPNPLMNATP53HTT | |
| Deoxyguanosine SCHEMBL10068103 | 1.00 | POLB (0.67) | POLBPNPLMNATP53HTT | |
| Deoxyguanosine SCHEMBL9561816 | 1.00 | POLB (0.67) | POLBPNPLMNATP53HTT | |
| Deoxyguanosine SCHEMBL14208980 | 1.00 | POLB (0.67) | POLBPNPLMNATP53HTT | |
| Deoxyguanosine SCHEMBL23892102 | 1.00 | POLB (0.67) | POLBPNPLMNATP53HTT | |
| Deoxyguanosine SCHEMBL9396414 | 1.00 | POLB (0.67) | POLBPNPLMNATP53HTT | |
| Deoxyguanosine SCHEMBL22992402 | 1.00 | POLB (0.67) | POLBPNPLMNATP53HTT | |
| Deoxyguanosine SCHEMBL23225364 | 1.00 | POLB (0.67) | POLBPNPLMNATP53HTT | |
| Deoxyguanosine SCHEMBL13318963 | 1.00 | POLB (0.67) | POLBPNPLMNATP53HTT | |
| Deoxyguanosine SCHEMBL13350959 | 1.00 | POLB (0.67) | POLBPNPLMNATP53HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 29418 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | claimed |
| EP-4748934-A1 | DNA APTAMER FOR INHIBITING FGFR1 | Masarykova Univerzita (CZ) | 2026-05-27 | — | — | EP | claimed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-12630822-B2 | Treatment of heart failure in human subjects | NOVO NORDISK A/S (DK) | 2026-05-19 | — | — | US | claimed |
| US-12630851-B2 | Polynucleotide modification methods | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-05-19 | — | — | US | claimed |
| WO-2026088246-A1 | METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND | ＮＴＴ株式会社 | 2026-04-30 | — | — | WO | claimed |
| US-20260109728-A1 | IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE | TALLAC THERAPEUTICS INC (US) | 2026-04-23 | — | — | US | claimed |
| US-20260103691-A1 | RNA POLYMERASE VARIANT AND USE THEREOF | NANJING VAZYME BIOTECH CO LTD (CN) | 2026-04-16 | — | — | US | claimed |
| US-12600964-B2 | Compound for treatment of heart failure | MEDIZINISCHE HOCHSCHULE HANNOVER (DE) | 2026-04-14 | — | — | US | claimed |
| US-20260097062-A1 | AQUEOUS SOLUTIONS CONTAINING PURINES AND PYRIMIDINES AND USES THEREOF | UCB BIOSCIENCES INC (US) | 2026-04-09 | — | — | US | claimed |
| US-4701323-A | PURINES CONJUGATED TO ANTIGENS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1987-10-20 | — | — | US | claimed |
| US-4594321-A | Reacting guanine derivative with phosphate | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1986-06-10 | — | — | US | claimed |
| US-4594320-A | Reacting guanine derivative with phosphate compound | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1986-06-10 | — | — | US | claimed |
| EP-0149775-A1 | Compositions of nucleic acid components | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1985-07-31 | — | — | EP | claimed |
| US-4469863-A | ANTITUMOR AGENTS, VIRICIDES | GENTA INCORPORATED | 1984-09-04 | — | — | US | claimed |
| EP-0113452-A2 | Magnetic particles as supports for organic synthesis | GENETICS INSTITUTE, INC. (US) | 1984-07-18 | — | — | EP | claimed |
| EP-0090417-A2 | Process for producing 3'-deoxyguanosine | Yamasa Shoyu Kabushiki Kaisha (JP) | 1983-10-05 | — | — | EP | claimed |
| US-4385112-A | CULTURES, PSEUDOMONAS, QUANTITATIVE NUCLEOSIDE ASSAY, MAKING NUCLEOSIDE-5-CARBOXYLIC ACIDS | TOYO JOZO KABUSHIKI KAISHA (JP) | 1983-05-24 | — | — | US | claimed |
| EP-0076647-A2 | Culture media for cells originating from the immune system | HANA Biologics Incorporated (US) | 1983-04-13 | — | — | EP | claimed |
| US-3956064-A | BACILLUS CULTURE, ENZYME SPECIFICITY | RIKAGAKU KENKYUSHO (JA) | 1976-05-11 | — | — | US | claimed |